Literature DB >> 11511360

Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.

J M Espinosa1, B M Emerson.   

Abstract

The tumor suppressor protein, p53, plays a critical role in mediating cellular response to stress signals by regulating genes involved in cell cycle arrest and apoptosis. p53 is believed to be inactive for DNA binding unless its C terminus is modified or structurally altered. We show that unmodified p53 actively binds to two sites at -1.4 and -2.3 kb within the chromatin-assembled p21 promoter and requires the C terminus and the histone acetyltransferase, p300, for transcription. Acetylation of the C terminus by p300 is not necessary for binding or promoter activation. Instead, p300 acetylates p53-bound nucleosomes in the p21 promoter with spreading to the TATA box. Thus, p53 is an active DNA and chromatin binding protein that may selectively regulate its target genes by recruitment of specific cofactors to structurally distinct binding sites.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511360     DOI: 10.1016/s1097-2765(01)00283-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  165 in total

1.  Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo.

Authors:  M D Kaeser; R D Iggo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 2.  Control of the G2/M transition.

Authors:  George R Stark; William R Taylor
Journal:  Mol Biotechnol       Date:  2006-03       Impact factor: 2.695

3.  Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.

Authors:  Penny G Ard; Chandrima Chatterjee; Sudeesha Kunjibettu; Leon R Adside; Lisa E Gralinski; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

4.  p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage.

Authors:  Carlos P Rubbi; Jo Milner
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

5.  Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.

Authors:  Kristine McKinney; Carol Prives
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

6.  Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.

Authors:  Dakang Xu; Trevor J Wilson; David Chan; Elisabetta De Luca; Jiong Zhou; Paul J Hertzog; Ismail Kola
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

7.  Transcription coactivator CBP has direct DNA binding activity and stimulates transcription factor DNA binding through small domains.

Authors:  Chao Zhong Song; Kimberly Keller; Yangchao Chen; Ken Murata; George Stamatoyannopoulos
Journal:  Biochem Biophys Res Commun       Date:  2002-08-09       Impact factor: 3.575

Review 8.  Pioneer factors and their in vitro identification methods.

Authors:  Xinyang Yu; Michael J Buck
Journal:  Mol Genet Genomics       Date:  2020-04-15       Impact factor: 3.291

Review 9.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

10.  A Designed Enzyme Promotes Selective Post-translational Acylation.

Authors:  Pallavi M Gosavi; Megha Jayachandran; Joel J L Rempillo; Oleksii Zozulia; Olga V Makhlynets; Ivan V Korendovych
Journal:  Chembiochem       Date:  2018-06-21       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.